NewsRx

Search our medical news database

Generex Biotechnology Corp.

Company wins U.S. patent for buccal delivery of pain-relief medications

Published in Medical Patent Week, March 20th, 2005

Generex Biotechnology Corp. (GNBT), a buccal-drug-delivery company, announced that it has been granted another United States patent.

The patent, entitled "Pharmaceutical compositions for buccal delivery of pain-relief medications," relates to a narcotic analgesic formulation delivered into the human body by way of the buccal mucosa in the mouth.

The formulations covered by the patent are applications of the company's proprietary RapidMist drug-delivery technology and, according to the company, are designed to deliver pain-relief medications such as morphine and fentanyl in a safe, simple, fast, effective and convenient alternative to injections and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook